Reply to A. Ruggiero et al. to our article 'Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity'

J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e20-e21. doi: 10.1111/jdv.18542. Epub 2022 Aug 29.

Authors

Rafaele Molinier¹, Anissa Roger^{1

2}, Bastien Genet³, Philippe Saiag^{1

2}, Elisa Funck-Brentano^{1

2}

Affiliations

¹ Department of General and Oncologic Dermatology, Ambroise-Paré Hospital, AP-HP, Boulogne-Billancourt, France.
² Research Unit EA4340 "Biomarkers and Clinical Trials in Oncology and Onco-Hematology", Versailles-Saint-Quentin-en-Yvelines University, Paris-Saclay University, 91190, France.
³ Department of Statistics and Methodology on Biomedical Research, Kremlin-Bicêtre University, Paris-Saclay University, 91190, France.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Communicable Disease Control
Humans
Melanoma* / diagnosis
Melanoma* / epidemiology
Pandemics / prevention & control
SARS-CoV-2